Cite

HARVARD Citation

    Latimer, N. et al. (n.d.). Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy. Cancer medicine. pp. 806-815. [Online]. 
  
Back to record